| Date | Title | Description |
| 13.03.2024 | Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution | - |
| 25.05.2023 | Agile Therapeutics Announces Closing of $7.5 Million Public Offering | - |
| 22.05.2023 | Agile Therapeutics Announces Pricing of $7.5 Million Public Offering | - |
| 11.05.2023 | Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update | /EIN News/ -- Twirla Delivers Single-Quarter Records for Retail and Non-Retail Demand; Both Channels Up 20% in First Quarter 2023 vs Fourth Quarter 2022
Total OPEX down 8% in First Quarter 2023 vs Fourth Quarter 2022
Company Reaffirms Expec... |
| 06.07.2022 | Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering | PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its previously announced up... |
| 01.07.2022 | Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering | PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering... |
| 11.04.2022 | Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program | PRINCETON, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the receipt of $4.7 million in net proceeds from the sale of tax benefits pursuant to the Company’s p... |
| 14.03.2022 | Agile Therapeutics Announces $4.85 Million Registered Direct Offering | PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has entered into a securities pur... |
| 14.03.2022 | Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering | PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has closed its previously announc... |
| 02.11.2021 | Agile Therapeutics Reports Third Quarter 2021 Financial Results | Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed
Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021
Company Advances Programs Focused on Increasing Demand for Twirl... |
| 02.11.2021 | AGILE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K | AGILE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed
Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021
... |
| 08.10.2021 | Agile Therapeutics : Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants | PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants ... |
| 08.10.2021 | Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants | PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants ... |
| 28.09.2021 | Agile Therapeutics : Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics | DGAP-News: Agile Therapeutics
Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics
28.09.2021 / 20:52
The issuer is solely responsible for the content of ... |
| 28.09.2021 | PRESS RELEASE : Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics | DGAP-News: Agile Therapeutics Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics 2021-09-28 / 20:52 The issuer is solely responsible for the content of ... |
| 28.09.2021 | Agile Therapeutics : Partners with Carli Lloyd, U.S. Womenâ™s Soccer Star and Four-Time Olympian, to Bring Awareness to Womenâ™s Health Topics | (via NewsDirect)
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today a partnership with U.S. Women’s Soccer legend,
Carli Lloyd. The partnership with Agile will focus on bringing awareness to women’s healt... |
| 01.03.2021 | Agile Therapeutics, Inc. announced that it has received $45 million in funding from Perceptive Advisors LLC | On March 1, 2021, the company amended the terms of the transaction. The company now raised $45 million in the transaction. The investor provided additional $10 million in its fourth tranche close. |
| 03.01.2017 | Two biotech stocks crash on first trading day of the year | Lexington, Massachusetts-based Inotek took a 68 percent hit for its lead candidate trabodenoson, in development for patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH).
The drug was reportedly well tolerated, but it... |
| 24.02.2015 | Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial | PRINCETON, N.J., Feb. 24, 2015 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announc... |
| 20.01.2015 | Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update | PRINCETON, New Jersey, Jan. 20, 2015 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, a... |
| 19.07.2012 | Agile Therapeutics Closes $40M Series C Financing | Agile Therapeutics, a Princeton, NJ-based pharmaceutical development company specializing in Women’s Healthcare products, has closed a $40m Series C financing.
The round was led by new investor Aisling Capital, LLC, with participation from ... |
| 25.10.2011 | At Biotech 2011, companies identify financing options | Government funding. If you want government funding, get to know your local congressmen, one panelist advised. Government grants can be a useful source of funding, particularly the Department of Defense. It might take time and the applicatio... |
| 14.06.2010 | Agile Therapeutics Completes $45M Series B Preferred Stock Financing | Agile Therapeutics, Inc., a Princeton, NJ-based late-stage pharmaceutical company specializing in women’s healthcare products, completed a $45m Series B Preferred Stock financing.
The round was co-led by Investor Growth Capital and Care Cap... |
| 23.10.2008 | Nora Pharma reels in $25M for women’s health | Nora Pharmaceuticals, developer of women’s reproductive health drugs and devices, brought in $25 million in first round financing from Burrill & Co., Prospect Venture Partners and Vivo Ventures. The San Francisco-based company is still ... |
| 20.12.2007 | Life sciences briefing: Thursday, Dec. 20, 2007 | Acorn Cardio raises $22M for heart-failure device — St. Paul, Minn.-based Acorn Cardiovascular, a device maker investigating a device that would restrain the expansion of failing hearts, raised $22 million in a new funding round. Investors ... |
| - | At Biotech 2011, companies identify financing options | The challenge of identifying and establishing financing for early and mid-stage companies is forcing companies to be more creative and making the series of panel discussions on the subject at Biotech 2011 in Philadelphia a high priority as ... |
| - | Two biotech stocks crash on first trading day of the year | Lest we forget how brutal the biotech sector can be, two microcap companies had their share prices slashed close to 70 percent on Tuesday — the first trading day of 2017.
Inotek Pharmaceuticals and Agile Therapeutics were independently obli... |
